Retreatment of recurrent pelvic tumors with iodine-125.
We describe our experience with successful retreatment of common pelvic tumors including recurrent cervical and endometrial cancer, colorectal cancer, and soft tissue sarcomas. Two different permanent interstitial 125iodine (125I) endocurietherapy (ECT) techniques were employed. The first technique, percutaneous transperineal template 125I ECT, was used in the retreatment of recurrent tumors located within the true pelvis. The second technique, implantation of 125I in Vicryl carrier following celiotomy, was used for retreatment of recurrent tumors located outside the true pelvis within the false pelvis.
Kumar
P P
PP
Department of Radiology, University of Nebraska College of Medicine, Omaha.
Good
R R
RR
Jones
E O
EO
Bartone
F F
FF
Scott
J C
JC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000379:methods; D002277:Carcinoma / Q000532:radiotherapy* / Q000556:secondary; D005260:Female; D005354:Fibrosarcoma / Q000532:radiotherapy* / Q000556:secondary; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D010386:Pelvic Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D010502:Perineum; D012004:Rectal Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms; D014594:Uterine Neoplasms
D007457:Iodine Radioisotopes